Novo A/S
Novo A/S, the holding company in the Novo Group, was established prior to the de-merger of Novo Nordisk in 2000. Novo A/S is a private limited liability company fully owned by the Novo Nordisk Foundation. Besides being the majority shareholder in Novo Nordisk A/S and Novozymes A/S, Novo A/S provides seed and venture capital to development stage companies within life science and biotechnology, as well as manages a broad portfolio of financial assets. For further information visit
